Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

The Surviving Sepsis Campaign Creates COVID-19 Guideline

By Sean Hickey, MD; and Melissa Villars, MD, MPH | on November 23, 2021 | 0 Comment
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
shutterstock.com
shutterstock.com

Editors’ Note: This article was accepted on Sept. 7, 2021, and was accurate at that time. Because information about COVID-19 is evolving rapidly, please verify these recommendations and information.

You Might Also Like
  • Opinion: How the Surviving Sepsis Campaign Got Almost Everything Wrong
  • ACEP Endorses Latest Surviving Sepsis Campaign Recommendations
  • ACEP Sepsis Task Force Report Delivers Key Insights
Explore This Issue
ACEP Now: Vol 40 – No 11 – November 2021

The COVID-19 pandemic continues to affect billions throughout the world. The rapidly growing evidence base creates a challenge for clinicians worldwide. The dynamic nature of this evidence further makes it difficult to create timely clinical guidelines, which are normally created on the scale of months to years. Thus, professional societies have adjusted their methods on how to develop guidelines during the pandemic.

The ACEP Clinical Policies Committee regularly assesses the guidelines produced by other medical specialty societies facilitated by a presentation and discussion led by the Emergency Medicine Residents’ Association (EMRA) representative to the Clinical Policies Committee. In light of the pandemic, the Surviving Sepsis Campaign created a dedicated panel, the Surviving Sepsis Campaign (SCC) COVID-19 panel, to establish and maintain guidelines to address the ever-growing body of evidence. Here we will briefly examine the “Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU.”

Guideline Process

The SSC implemented a living guideline model to provide continually updated guidance on the treatment of COVID-19. The panel released its original guideline on the management of COVID-19 in June 2020 with a subsequent update published in March 2021.1,2 The SSC COVID-19 panel includes a diverse range of experts from guideline development, infection control, infectious diseases and microbiology, critical care, hematology and thrombosis, surgery, emergency medicine, nursing, pharmacy, and public health. Eight new members were added to the panel from the prior iteration. All members had to disclose their conflict of interests (COI) and were not able to vote if they had a COI related to the guideline question. The panel utilized the GRADE methodology and the Evidence to Decision (EtD) Framework to develop the recommendations.3,4 The EtD Framework provides a structured approach that helps make the assessment and integration of the evidence, and other patient-centered considerations more systematic and explicit to generate rigorous recommendations. 

Professional medical librarians performed a literature search through Cochrane Central Register of Controlled Trials and the National Library of Medicine’s MEDLINE databases. Trained reviewers screened the literature search and removed duplicates. Random-effects meta-analysis was done when applicable, based upon the data. The GRADE approach was utilized to assess the quality of evidence.3 Only direct evidence (evidence generated from studies on COVID-19) was included in the March 2021 update, as opposed to the prior guideline which included indirect evidence (evidence from more general disease process such as acute respiratory distress syndrome). The exception to this is questions regarding anticoagulation, as direct evidence was not available.

Pages: 1 2 | Single Page

Topics: Clinical GuidelineCOVID-19GuidelinesSepsis

Related

  • Dr. Joe Sachs and “The Pitt” Are Redefining Public Health Education Through Storytelling

    June 11, 2025 - 0 Comment
  • June 2025 News from the College

    June 5, 2025 - 0 Comment
  • Discharge Tachycardia: Remember the Big 4 and Don’t Play with Fire

    May 8, 2025 - 2 Comments

Current Issue

ACEP Now: June 2025 (Digital)

Read More

No Responses to “The Surviving Sepsis Campaign Creates COVID-19 Guideline”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603